Jaleh Fallah

13PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 03, 2026
Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.

Michael S Leapman, Jessica B Long, Sarah Westvold

|Sep 17, 2024
Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies.

Jaleh Fallah, Flora Mulkey, Mallorie H Fiero

|Sep 09, 2024
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma.

Jaleh Fallah, Brian L Heiss, Hee-Koung Joeng

|Aug 29, 2024
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations.

Jaleh Fallah, Jianjin Xu, Hee-Koung Joeng

|Mar 15, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis.

Jaleh Fallah, Haley Gittleman, Chana Weinstock

|Mar 14, 2024
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis.

Jaleh Fallah, Jianjin Xu, Chana Weinstock

Pageof 3

Frequent Collaborators

6 joint publications

Laleh Amiri-Kordestani

6 joint publications

Richard Pazdur

4 joint publications

Jianjin Xu

4 joint publications

Elaine Chang